Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aldeyra Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aldeyra Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Aldeyra Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is ALDX. The reporting company's CIK number is 1341235.
The total value of stock buying since 2005 is $11,994,784.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $1,000,224.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-19||Edelman Joseph (10% Owner)||Buy||200,000||7.25||1,450,000|
|2017-06-30||Edelman Joseph (10% Owner)||Buy||296,007||4.60||1,361,632|
|2017-02-17||Bronstein Ben (Director)||Buy||4,444||4.50||19,998|
|2017-02-17||Brady Todd C (President and CEO)||Buy||22,223||4.50||100,003|
|2017-02-17||Tulipano Stephen J (Chief Financial Officer)||Buy||3,333||4.50||14,998|
|2017-02-17||Joyce Martin Joseph (Director)||Buy||4,444||4.50||19,998|
|2017-02-14||Perceptive Life Sciences Master Fund Ltd||Buy||893,025||4.50||4,018,612|
|2016-05-26||Perceptive Life Sciences Master Fund Ltd||Buy||700,000||5.00||3,500,000|
|2015-10-28||Perceptive Life Sciences Master Fund Ltd||Buy||45,100||6.50||293,150|
|2015-10-26||Perceptive Life Sciences Master Fund Ltd||Buy||50,000||6.46||323,150|
|2015-10-22||Perceptive Life Sciences Master Fund Ltd||Buy||18,020||6.47||116,661|
|2015-10-20||Perceptive Life Sciences Master Fund Ltd||Buy||37,145||6.37||236,576|
|2014-08-07||Joyce Martin Joseph (Director)||Buy||1,000||3.95||3,948|
|2014-08-06||Clarke C. Boyd (Director)||Buy||3,000||3.69||11,058|
|2014-05-07||Bronstein Ben (Director)||Buy||12,500||8.00||100,000|
|2014-05-07||Walker Neal (Director)||Buy||6,250||8.00||50,000|
|2014-05-07||Clarke C. Boyd (Director)||Buy||12,500||8.00||100,000|
|2014-05-07||Brady Todd C (President and CEO)||Buy||12,500||8.00||100,000|
|2014-05-07||Joyce Martin Joseph (Director)||Buy||12,500||8.00||100,000|
|2014-05-07||Phillips Gary M. (Director)||Buy||9,375||8.00||75,000|
|2014-05-01||Vitullo Nicole (10% Owner)||Option Ex||121,152||5.16||625,144|
|2014-05-01||Johnson & Johnson Development Corp Et Al (10% Owner)||Option Ex||72,690||5.16||375,080|
Insider trading activities including stock purchases, stock sales, and option exercises of ALDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aldeyra Therapeutics, Inc. (symbol ALDX, CIK number 1341235) see the Securities and Exchange Commission (SEC) website.